About Us
Innovating at the Intersection of Regeneration and Critical Care
About Kollo Biotech
Kollo Biotech is a science-driven pharmaceutical company committed to advancing regenerative wound management and high-potency critical care therapeutics.
Built on over three decades of pharmaceutical expertise, the company integrates regenerative collagen biotechnology with next-generation anti-infective solutions to address complex clinical challenges including chronic diabetic foot ulcers, severe burns, ICU-acquired infections, and antimicrobial resistance.
Our Vision
To become a nationally recognized leader in regenerative and critical care therapeutics by combining biological science with clinical precision.
Bivesh Ram K P
Chief Executive Officer (CEO) – Kollo Biotech
A dynamic healthcare industry professional, Mr. Bivesh Ram K P leads the strategic growth and operational development of Kollo Biotech. As CEO, he focuses on expanding the company’s presence in advanced wound management and critical care therapeutics across hospitals and clinical networks.
Delivering Trusted Therapeutic Solutions Across India
